Sandra Irenaeus

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Hamid, O.; Ekström-Rydén, Viktoria; Mehmi, I.; Wang, D. et al.

Ingår i Nature Communications, 2026

• DOI för LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
• Ladda ner fulltext (pdf) av LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i BJUI Compass, 2025

• DOI för Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Ladda ner fulltext (pdf) av Potential gains from radical treatment of men with prostate cancer according to life expectancy

Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Johansson, Anna L. V.; Skog, Anna; Johannesen, Tom Børge; Myklebust, Tor Åge et al.

Ingår i Acta Oncologica, s. 257-266, 2025

• DOI för Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries
• Ladda ner fulltext (pdf) av Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Ingår i PLOS ONE, 2024

• DOI för Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

Johansson, Anna L.; Skog, Anna; Johannesen, Tom Borge; Myklebust, Tor age et al.

Ingår i The Lancet Regional Health, 2023

• DOI för Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era
• Ladda ner fulltext (pdf) av Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Hamid, O.; Ekström-Rydén, Viktoria; Mehmi, I.; Wang, D. et al.

Ingår i Nature Communications, 2026

• DOI för LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
• Ladda ner fulltext (pdf) av LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i BJUI Compass, 2025

• DOI för Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Ladda ner fulltext (pdf) av Potential gains from radical treatment of men with prostate cancer according to life expectancy

Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Johansson, Anna L. V.; Skog, Anna; Johannesen, Tom Børge; Myklebust, Tor Åge et al.

Ingår i Acta Oncologica, s. 257-266, 2025

• DOI för Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries
• Ladda ner fulltext (pdf) av Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Ingår i PLOS ONE, 2024

• DOI för Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

Johansson, Anna L.; Skog, Anna; Johannesen, Tom Borge; Myklebust, Tor age et al.

Ingår i The Lancet Regional Health, 2023

• DOI för Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era
• Ladda ner fulltext (pdf) av Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Ingår i Journal of Clinical Epidemiology, s. 22-30, 2023

• DOI för Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Ladda ner fulltext (pdf) av Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Irenaeus, Sandra; Hellström, Vivan; Wenthe, Jessica; Krause, Johan et al.

Ingår i Cancer Gene Therapy, s. 1188-1197, 2021

• DOI för Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Schiza, Aglaia; Irenaeus, Sandra; Ortiz-Nieto, Francisco; Loskog, Angelica S. et al.

Ingår i Scientific Reports, 2019

• DOI för Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients
• Ladda ner fulltext (pdf) av Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies

Irenaeus, Sandra; Nielsen, Dorte; Ellmark, Peter; Yachnin, Jeffrey et al.

Ingår i International Journal of Cancer, s. 1189-1199, 2019

• DOI för First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Irenaeus, Sandra; Schiza, Aglaia; Mangsbo, Sara M.; Wenthe, Jessica et al.

Ingår i Oncotarget, s. 78573-78587, 2017

• DOI för Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
• Ladda ner fulltext (pdf) av Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer

Eriksson, Emma; Wenthe, Jessica; Irenaeus, Sandra; Loskog, Angelica et al.

Ingår i Journal of Translational Medicine, 2016

• DOI för Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer
• Ladda ner fulltext (pdf) av Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer

Intratumoral CD40 stimulating therapy in patients with advanced cancer

Irenaeus, Sandra

2021

• Ladda ner fulltext (pdf) av Intratumoral CD40 stimulating therapy in patients with advanced cancer

Safety of intratumoral immunostimulatory LOAd703 gene therapy in patients with advanced cancer

Irenaeus, Sandra; Wenthe, Jessica; Eriksson, Emma; Schiza, Aglaia et al.

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Immunological evaluation of immunostimulatory gene therapy targeting CD40/4-1BB in advanced cancer patients (LOKON002)

Wenthe, Jessica; Eriksson, Emma; Naseri, Sedigheh; Sandin, Linda et al.